Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Custodiol-N vs Custodiol in Pediatric Cardiac Surgery
NCT07381530Phase 2Suspended
- Sponsor
- Franz Köhler Chemie
- Start
- Dec 2024
- Primary completion
- Dec 2026
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
A Phase 2 trial of histidine-tryptophan-ketoglutarate solution (modified) in congenital heart defect (CHD), sponsored by Franz Köhler Chemie. Started Dec 2024; status: suspended.
02
Drugs
histidine-tryptophan-ketoglutarate solution (modified)
03
Conditions
congenital heart defect (CHD)
Beyond the preview
Go deeper on NCT07381530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07381530.